{"id":717321,"date":"2024-10-17T18:22:01","date_gmt":"2024-10-17T18:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=717321"},"modified":"2024-10-17T18:22:01","modified_gmt":"2024-10-17T18:22:01","slug":"medical-device-contract-manufacturing-market-to-reach-usd-16799-billion-by-2031-attributed-to-rising-demand-for-biosimilars-and-monoclonal-antibodies","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/medical-device-contract-manufacturing-market-to-reach-usd-16799-billion-by-2031-attributed-to-rising-demand-for-biosimilars-and-monoclonal-antibodies_717321.html","title":{"rendered":"Medical Device Contract Manufacturing Market to Reach USD 167.99 Billion by 2031, Attributed to Rising Demand for Biosimilars and Monoclonal Antibodies"},"content":{"rendered":"
\n
\"Medical<\/a><\/div>\n
\n
Medical Device Contract Manufacturing Market<\/div>\n<\/div>\n<\/div>\n
Medical Device Contract Manufacturing Market size was valued at USD 63.58 billion in 2022 and is poised to grow from USD 70.83 billion in 2023 to USD 167.99 billion by 2031, growing at a CAGR of 11.4% in the forecast period (2024-2031).<\/div>\n

The growth of the medical device contract manufacturing market<\/strong><\/a> is derived from the factors such as increasing demand for monoclonal antibodies and biosimilars, increasing demand for target diseases, and the rapidly growing utilization of immunotherapy drug classes in contrast to traditional treatment strategies. Moreover, the increasing demand for personalized healthcare is likely to aid in future market growth. In addition, over the given forecast period, growth in the market is brought about by the growing healthcare costs in the developed economies and an aging population. Growth drivers for this market are increasing adoption of robotics, automation and technological advancement in medical devices.<\/p>\n

Request your free sample PDF of the report today<\/strong>: https:\/\/www.skyquestt.com\/sample-request\/medical-device-contract-manufacturing-market<\/a>  <\/p>\n

Impact of 3D Printing on Patient-Specific Solutions<\/strong><\/p>\n

The power of 3D printing brings about a change in medical device contract manufacturing as it enables the possibility of making custom and rapid production. It truly shows much promise to areas such as prosthetics, metal and polymeric implants, even to patient-specific jigs tailored specifically to respond to customized demands. This is exactly what BAAT Medical reported with Belgian contract manufacturer Amnovis back in June 2022. Together, they designed a new way of making medical equipment through 3D printing, not only something new but also efficient, which drastically reduced turnaround times. Today, with the demand for customized medical solutions on the rise, 3D printing is surely going to play a major role in this market.<\/p>\n

Leading Companies in Medical Device Contract Manufacturing<\/strong><\/p>\n

The medical device contract manufacturing market has moderate competition with a few key manufacturers taking a significant share of the market. The major players such as Invetech, Jabil Inc., Synecco, Gerresheimer AG, and Biofortuna Limited- are all on an acquisition spree to increase their global presence. This trend enhances their in-house innovation capabilities and high-volume manufacturing capacities further while fortifying their market position. This is changing the market scenario fast because these major business houses are making forays into other markets through strategic alliances and acquisitions, and all this is encouraging more rivalry among the participants in the industry and cooperation.<\/p>\n

For a tailored report, contact us to request a free customization<\/strong>: https:\/\/www.skyquestt.com\/speak-with-analyst\/medical-device-contract-manufacturing-market<\/a><\/p>\n

Strategic Moves by Key Players<\/strong><\/p>\n

In March 2024, due to the agreement on manufacturing representation that was signed with HnG Medical Incorporated, a health industry key player from the Chinese side, Medibrane Ltd. has achieved this important milestone as highly regarded one of the principal contract manufacturers in the medical device business.<\/p>\n

In March 2024, KBI Biopharma and Argonaut Manufacturing Services announced a strategic partnership.<\/p>\n

In May 2022, Biomerics, one of the leading vertically integrated medical device contract manufacturers for the interventional device industry, has opened its 2,000 square foot balloon and balloon catheter center of excellence in Galway, Ireland. This is its second location outside of the US, following on from Costa Rica, and its first in Europe.<\/p>\n

This report covers the following segments:<\/strong><\/p>\n

A. Device Type<\/strong><\/p>\n

IVD Devices<\/p>\n

Diagnostic Imaging Devices<\/p>\n

Cardiovascular Devices<\/p>\n

Drug Delivery Devices<\/p>\n

Orthopedic Devices<\/p>\n

Respiratory Care Devices<\/p>\n

Ophthalmology Devices<\/p>\n

Surgical Devices<\/p>\n

Diabetes Care Devices<\/p>\n

Dental Device<\/p>\n

Endoscopy & Laparoscopy Devices<\/p>\n

Gynecology\/Urology Devices<\/p>\n

Personal Care Devices<\/p>\n

Neurology Devices<\/p>\n

Patient Monitoring Devices<\/p>\n

Patient Assistive Devices<\/p>\n

Other Devices<\/p>\n

B. Device Class<\/strong><\/p>\n

Class I: General controls<\/p>\n

Class II: General controls with special controls<\/p>\n

Class III: General controls, special controls, and premarket approval<\/p>\n

C. Service<\/strong><\/p>\n

Device Development and Manufacturing<\/p>\n

Quality Management<\/p>\n

Packaging and Assembly Services<\/p>\n

Other Services<\/p>\n

This report covers the following players:<\/strong><\/p>\n

Jabil Inc.<\/p>\n

Flex, Ltd.<\/p>\n

Plexus Corp.<\/p>\n

Integer Holdings Corporation <\/p>\n

Celestica Inc. (Canada)<\/p>\n

West Pharmaceutical Services, Inc. <\/p>\n

Benchmark Electronics Inc. <\/p>\n

Kimball Electronics, Inc. <\/p>\n

Nortech Systems, Inc. <\/p>\n

Phillips-Medisize Corporation <\/p>\n

Tessy Plastics Corp. <\/p>\n

Tekni-Plex <\/p>\n

Recipharm AB<\/p>\n

Gerresheimer AG<\/p>\n

Carclo PLC<\/p>\n

Nemera<\/p>\n

SMC Ltd.<\/p>\n

Sanmina Corporation<\/p>\n

Nipro Corporation<\/p>\n

NOLATO GW, Inc.<\/p>\n

Mehow<\/p>\n

Purchase now to gain valuable insights and stay informed<\/strong>: https:\/\/www.skyquestt.com\/buy-now\/medical-device-contract-manufacturing-market<\/a><\/p>\n

Capitalizing on Global Medical Device Demand<\/strong><\/p>\n

Ever-increasing medical equipment and gadget demand globally is making medical device contract manufacturing highly beneficial. The long-term future revenue growth is humongous for companies that get involved in contract manufacturing medical devices. All companies that make medical device contract manufacturing are going to be successful in finding profitable business by targeting developing countries and other medical device startups.<\/p>\n

To read the full report, please visit<\/strong>: https:\/\/www.skyquestt.com\/report\/medical-device-contract-manufacturing-market<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Skyquest Technology<\/a>
Contact Person:<\/strong> Mr. Jagraj Singh
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 351-333-4748
Address:<\/strong>1 Apache Way, Westford,
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.skyquestt.com\/report\/medical-device-contract-manufacturing-market<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Medical Device Contract Manufacturing Market Medical Device Contract Manufacturing Market size was valued at USD 63.58 billion in 2022 and is poised to grow from USD 70.83 billion in 2023 to USD 167.99 billion by 2031, growing at a CAGR … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,403,404],"tags":[],"class_list":["post-717321","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/717321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=717321"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/717321\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=717321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=717321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=717321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}